-
13 Mai 2026
-
13 Mai 2026
Annual General Meeting of Ipsen S.A. held on 13 May 2026
Annual General Meeting of Ipsen S.A. held on 13 May 2026...
-
17 Avril 2025
- 0 mn de lecture
-
17 Avril 2025
- 0 mn de lecture
-
21 Mai 2025
-
21 Mai 2025
Ipsen S.A. – Annual General Meeting held on 21 May 2025
Annual General Meeting of Ipsen S.A. held on 21 May 2025...
-
21 Mai 2025
-
21 Mai 2025
-
30 Avril 2025
-
30 Avril 2025
Ipsen S.A. – Formalities for making available and consulting preparatory documents to the 2025 Annual General Meeting
Information relating to the holding of the Combined Shareholders’ Meeting of 21 May 2025 of Ipsen S.A....
-
08 Juin 2026
- 2 mn de lecture
-
08 Juin 2026
- 2 mn de lecture
Biopharma deals thrive on creativity, from structure through to execution
Philippe Lopes‑Fernandes, Chief Business Officer ...
-
08 Juin 2026
- 3 mn de lecture
-
08 Juin 2026
- 3 mn de lecture
Dans la biopharma, la créativité est au cœur des partenariats, de la structure à l’exécution
Philippe Lopes‑Fernandes, Directeur des opérations ...
-
13 Mai 2026
-
13 Mai 2026
Ipsen S.A. – Evolution of the composition of the Board of Directors
Ipsen S.A. – Evolution of the composition of the Board of Directors...
-
23 Juillet 2025
-
23 Juillet 2025
Ipsen announces changes to its Executive Committee
PARIS, FRANCE, 23 July 2025 - Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty care biopharmaceutical company, today announced the following changes to its Executive Committee:...